Key result
Non-invasive imaging detects ischemic cardiomyopathy with ~86% sensitivity and specificity.
Meta-Analysis (n=862)
This review highlights the need to recognize ischemic cardiomyopathy as a distinct clinical entity to improve research consensus, diagnosis, and clinical management.
Answers are grounded in this paper and cite their sources.
Supports non-invasive imaging for ischemic cardiomyopathy detection; leaves open prospective validation and consensus on distinct entity.
Ischemic heart disease is the leading cause of sudden cardiac death. It may lead to cardiomyopathy in the setting of coronary artery disease and gradually progressing to heart failure. While ischemic cardiomyopathy is a well-recognized disease entity, the current classification systems of cardiomyopathy exclude cardiomyopathies secondary to ischemia. Further, research on ischemic cardiomyopathy is extensively fragmented, which has undermined both research consensus and comprehensive understanding. The fragmentation is attributable to its variable terminologies (ischemic heart disease or its three leading non-fatal sequela -angina pectoris, acute myocardial infarction and ischemic heart failure). Therefore, the purpose of the present review is to accumulate research on ischemic cardiomyopathy to produce a comprehensive understanding of its clinical status, diagnosis, clinical management and improve survival.
No takes yet. Share an insight, caveat, or question.
Aref Albakri (2018) conducted a meta-analysis in Ischemic cardiomyopathy (n=862). Non-invasive imaging modalities (CMRI, SPECT/PET, CT, Echocardiography) was evaluated on Diagnostic sensitivity and specificity. Non-invasive imaging methods, including cardiac MRI, SPECT/PET, and echocardiography, demonstrated a high mean diagnostic specificity and sensitivity of 86% in the detection of ischemic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: